TZ 10mg
What is TZ?
TZ is a synthetic dual-agonist peptide studied for its activity at both GLP-1 and GIP receptors. Research literature highlights its role in studies of glucose regulation, appetite signaling, and body composition models.
This 10mg research vial provides a starter quantity suitable for short-protocol in-vitro and pre-clinical investigation under controlled laboratory conditions.
Research Benefits
- Studied for appetite signal modulation
- Dual GIP + GLP-1 receptor engagement
- Investigated for body composition models
- Researched for insulin sensitivity pathways
How It Works
TZ engages two distinct incretin receptors (GIP and GLP-1) in research models, producing a complementary signaling effect studied across metabolic and adipose pathways.
Certificate of Analysis
Third-party HPLC results for TZ 10mg, lot 082026glptz10G.
- Analyte
- Tirzepatide
- Batch / Lot
- 082026glptz10G
- Result
- 10.11 mg/vial
- Label Claim
- 10 mg/vial
- Chromatographic Purity
- >99%
- Method
- HPLC
- Date Tested
- 08/26/2026
Why Choose PWR Peptides?
- Research Use Only
Every product is intended strictly for laboratory and research applications.
- Secure Packaging
Discreet, temperature-conscious packaging protects each vial in transit.
- Fast Shipping
Most orders leave our US fulfillment center within 24 business hours.
- Responsive Support
Real humans reply to research and order questions, usually same-day.
- Batch Tracking
Batch identifiers are recorded for applicable products for full traceability.
Documentation is maintained for applicable product batches. Additional information may be available upon request when applicable. Contact support for inquiries.